Flu Takes Backseat to COVID-19: Survey of US Adults

News
Slideshow

Getting sick with COVID-19 is more worrisome to US adults than contracting the flu, the NFID found. How will that impact uptake of the flu shot this season?

Infection with influenza concerns a smaller proportion of US adults than contracting COVID-19, according to a survey conducted by the National Foundation for Infectious Diseases. And, while 61% of those surveyed agree that the best preventive measure against flu is the vaccination, 44% say they are unsure/do not plan to get a flu shot during the 2021-2022 flu season.

More attitudes, beliefs, and potential behaviors around the flu and its treatment and how COVID-19 has affected the way US adults perceive the threat follows in our slide-show summary of findings.

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!
Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Document COVID Sequelae and Primary Care: An Interview with Samoon Ahmad, MD
Related Content
Nirsevimab Highly Effective in Preventing RSV-Related LRTD in Healthy Term Infants, Real-World Study Finds

Nirsevimab Highly Effective in Preventing RSV-Related LRTD in Healthy Term Infants, Real-World Study Finds

Sydney Jennings
August 4th 2025
Article

Nirsevimab lowered the risk of RSV-related illness by over 87% and hospitalizations by 98% in a new study.

Weekly Dose: A Roundup of Top Stories for Primary Care Physicians

Weekly Dose: A Roundup of Top Stories for Primary Care Physicians

Sydney Jennings
August 4th 2025
Podcast

PODCAST: Listen to our first episode for new research on bacterial vaginosis, a new treatment option for chronic urticaria, and more.

Phase 3 Trials Begin for Once-Monthly Oral HIV Prevention Pill

Phase 3 Trials Begin for Once-Monthly Oral HIV Prevention Pill

Sydney Jennings
August 4th 2025
Article

Merck has launched phase 3 trials for MK-8527, a promising once-monthly HIV prevention pill, aiming to enhance PrEP options globally.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Keith A. Reynolds
August 4th 2025
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

New Data at IAS 2025 Underscore Real-World Success of Long-Acting Injectable HIV Therapies / Image credit: ©Ezume Images/AdobeStock

New Data at IAS 2025 Underscore Real-World Success of Long-Acting Injectable HIV Therapies

Sydney Jennings
August 4th 2025
Article

New findings showcase the transformative impact of long-acting injectable therapies for effective HIV treatment and prevention.

Clinic- and System-Level Factors Drive Racial Disparities in COVID-19 Antiviral Prescribing, Study Finds

Clinic- and System-Level Factors Drive Racial Disparities in COVID-19 Antiviral Prescribing, Study Finds

Sydney Jennings
August 4th 2025
Article

A new study found racial disparities in COVID-19 antiviral prescribing, with clinic site, test type, and telehealth use explaining up to half the gap for Black and Latino patients.

© 2025 MJH Life Sciences

All rights reserved.